Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for improving retroviral transduction and gene editing in hematopoietic stem cells using clyclosporin H and UM171

Method for improving retroviral transduction and gene editing in hematopoietic stem cells using clyclosporin H and UM171

US Patent 12485187 · Granted Dec 2, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Virus vector production2025
Systems and methods for treating hyper-igm syndrome2025
Systems and methods for treating hyper-igm syndrome2025
Permanent epigenetic gene silencing2024
Gene therapy2024
Method for improving retroviral transduction and gene editing in hematopoietic s2024
Method for improving retroviral transduction and gene editing in hematopoietic s2024
Method for improving retroviral transduction and gene editing in hematopoietic s2024
Method for improving retroviral transduction and gene editing in hematopoietic s2024
Method for improving retroviral transduction and gene editing in hematopoietic s2024
Method for improving retroviral transduction and gene editing in hematopoietic s2024
Vector production2024